Loading clinical trials...
Loading clinical trials...
A Phase 2 Clinical Study to Evaluate the Efficacy and Safety of CU-20401 for Injection in Moderate to Severe Contour Protuberance or Excessive Enrichment Due to Submental Fat (SMF) Accumulation
Conditions
Interventions
Subcutaneous injection of CU-20401
Locations
1
China
Union Hospital Tongji Medical College Huazhong University of Science and Technology
Wuhan, Hubei, China
Start Date
December 20, 2023
Primary Completion Date
September 2, 2024
Completion Date
September 2, 2024
Last Updated
January 22, 2025
NCT07256522
NCT03901235
NCT06562920
NCT06365541
NCT07362693
NCT06708871
Lead Sponsor
Cutia Therapeutics（Wuxi）Co.,Ltd
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions